Colossal's work extends beyond de-extinction, impacting conservation efforts for endangered species. The company collaborates with organizations like Re:wild and Save The Elephants, supporting initiatives to combat the biodiversity extinction crisis. Through its Colossal Foundation, the company funds research and develops genetic technologies to protect and restore vulnerable species. Strategic investors include TWG Global, USIT, and private individuals like Richard Garriott and Peter Jackson. Colossal's advancements in genetic engineering and synthetic biology are transforming species restoration and conservation science.
Key takeaways:
- Colossal BioSciences has raised $200 million in funding to advance its de-extinction projects, bringing its total funding to $435 million and valuing the company at $10.2 billion.
- The company is focused on bringing back extinct species like the woolly mammoth, thylacine, and dodo, leveraging advances in genetic engineering and synthetic biology.
- Colossal's efforts have led to significant breakthroughs in ancient DNA research, genome engineering, and species conservation, with implications for both de-extinction and the preservation of endangered species.
- The Colossal Foundation supports global conservation initiatives, partnering with organizations like Re:wild to apply genetic technologies to protect and restore vulnerable species.